Vivant Tumor Ablation Microwave Technology Augments Tyco Cool-Tip RF
This article was originally published in The Gray Sheet
Executive Summary
Tyco Healthcare's acquisition of Vivant Medical for more than $100 mil. will enable the manufacturer to launch VivaWave tissue ablation domestically early next year, following 510(k) clearance of a key system component
You may also be interested in...
Tyco Expands Direct Selling, Focuses R&D On Surgery, Radiopharmaceuticals
Tyco says its healthcare and electronics businesses are poised for acquisitions in the $500 mil. range, but that any purchases will complement and not diverge greatly from its current technology offerings
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.